Hymecromone (DrugBank: Hymecromone)
1 disease告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
94 | 原発性硬化性胆管炎 | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02780752 (ClinicalTrials.gov) | October 2018 | 17/5/2016 | A Study of Oral Hymecromone to Treat Adults With Primary Sclerosing Cholangitis | A Pilot Study of Oral Hymecromone to Treat Adults With Primary Sclerosing Cholangitis | Primary Sclerosing Cholangitis | Drug: hymecromone | Stanford University | NULL | Withdrawn | 18 Years | N/A | All | 0 | Phase 1;Phase 2 | United States |